{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:51:32Z","timestamp":1773993092243,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Council for Scientific, Technological Development","award":["CNPq-162876\/2020-3 process"],"award-info":[{"award-number":["CNPq-162876\/2020-3 process"]}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Council for Scientific, Technological Development  - CNPq"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00210-024-03379-y","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T05:02:28Z","timestamp":1724475748000},"page":"1013-1021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypericin-loaded in modified theranostic liposome nanoplatform: a preliminary in vivo study of targeting and diagnosis"],"prefix":"10.1007","volume":"398","author":[{"given":"Fl\u00e1via Amanda Pedroso","family":"de Morais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo Bento","family":"Balbinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Beatriz Kawano","family":"Bakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Lararin-Bidoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katieli","family":"da Silva Souza Campanholi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Ranulfo Combuca","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Martins","family":"de Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato Sonchini","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e2nia","family":"Ueda-Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sueli","family":"de Oliveira Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilker","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso Vataru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"issue":"3","key":"3379_CR1","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/polym12030598","volume":"12","author":"I Ali","year":"2020","unstructured":"Ali I, Alsehli M, Scotti L, Tullius Scotti M, Tsai S-T, Yu R-S, Hsieh MF, Chen J-C (2020) Progress in polymeric nano-medicines for theranostic cancer treatment. Polymers 12(3):598. https:\/\/doi.org\/10.3390\/polym12030598","journal-title":"Polymers"},{"issue":"26","key":"3379_CR2","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.2217\/nnm-2020-0290","volume":"15","author":"AC Apolinario","year":"2020","unstructured":"Apolinario AC, Hirata AS, Anjos Miguel RD, Costa-Lotufo LV, Pessoa A, La Clair JJ, Fenical W, Lopes LB (2020) Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine 15(26):2539\u20132542. https:\/\/doi.org\/10.2217\/nnm-2020-0290","journal-title":"Nanomedicine"},{"key":"3379_CR3","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1007\/s13277-015-3706-6","volume":"36","author":"B Bahrami","year":"2015","unstructured":"Bahrami B, Mohammadnia-Afrouzi M, Bakhshaei P et al (2015) Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy. Tumor Biol. 36:5727\u20135742. https:\/\/doi.org\/10.1007\/s13277-015-3706-6","journal-title":"Tumor Biol."},{"key":"3379_CR4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA: A Cancer J Clin"},{"key":"3379_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrd2243","volume":"6","author":"R Casero","year":"2007","unstructured":"Casero R, Marton L (2007) Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 6:373\u2013390. https:\/\/doi.org\/10.1038\/nrd2243","journal-title":"Nat Rev Drug Discov"},{"key":"3379_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154356","volume":"105","author":"N Choudhary","year":"2022","unstructured":"Choudhary N, Collignon TE, Tewari D, Bishayee A (2022) Hypericin and its anticancer effects: from mechanism of action to potential therapeutic application. Phytomedicine 105:154356. https:\/\/doi.org\/10.1016\/j.phymed.2022.154356","journal-title":"Phytomedicine"},{"key":"3379_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jlumin.2018.01.027","volume":"197","author":"SR De Lima","year":"2018","unstructured":"De Lima SR, Pereira GJ, Messias DN, Andrade AA, Oliveira E, Lodeiro C, Zilio SC, Pilla V (2018) Fluorescence quantum yield determination of molecules in liquids by thermally driven conical diffraction. J Lumins 197:175\u2013179. https:\/\/doi.org\/10.1016\/j.jlumin.2018.01.027","journal-title":"J Lumins"},{"key":"3379_CR8","doi-asserted-by":"publisher","unstructured":"de Morais FAP, Gon\u00e7alves RS, da Silva Souza Campanholi K, Martins de Fran\u00e7a B, Augusto Capeloto O, Lazarin-Bid\u00f3ia D, Balbinot RB, Nakamura CV, Carlos Malacarne L, Caetano W, Hioka N, (2021) Photophysical characterization of hypericin-loaded in micellar, liposomal and copolymer-lipid nanostructures based F127 and DPPC liposomes, Spectrochim. Acta A Mol Biomol Spectrosc 248:119173. https:\/\/doi.org\/10.1016\/j.saa.2020.119173","DOI":"10.1016\/j.saa.2020.119173"},{"key":"3379_CR9","doi-asserted-by":"publisher","unstructured":"de Morais FAP, De Oliveira ACV, Balbinot RB, Lazarin-Bid\u00f3ia D, Ueda-Nakamura T, de Oliveira Silva S, da Silva Souza Campanholi K, da Silva Junior RC, Gon\u00e7alves RS, Caetano W et al. (2023) Multifunctional nanoparticles as high-efficient targeted hypericin system for theranostic melanoma. Polymers, 15:179. https:\/\/doi.org\/10.3390\/polym15010179","DOI":"10.3390\/polym15010179"},{"key":"3379_CR10","doi-asserted-by":"publisher","unstructured":"De Oliveira ACV, de Morais FAP, de Silva Souza Campanholi K, Lazarin-Bid\u00f3ia D, Balbinot RB, Nakamura CV, Caetano W, Hioka N, Monteiro OS, Rocha CQ, Gon\u00e7alves RS (2022) Melanoma-targeted photodynamic therapy based on hypericin-loaded multifunctional P123-spermine\/folate micelles. Photodiagnos Photodynam Ther, 40, 103103. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.103103","DOI":"10.1016\/j.pdpdt.2022.103103"},{"key":"3379_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T (2023) Nanomedicine in cancer therapy. Signal Transduct Target Ther 8:29. https:\/\/doi.org\/10.1038\/s41392-023-01536-y","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3379_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1124\/jpet.119.257113","volume":"370","author":"PM Glassman","year":"2019","unstructured":"Glassman PM, Muzykantov VR (2019) J Pharmacol Exp Ther 370(3):570\u2013580. https:\/\/doi.org\/10.1124\/jpet.119.257113","journal-title":"J Pharmacol Exp Ther"},{"key":"3379_CR13","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1080\/14786419.2018.1457661","volume":"33","author":"RS Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves RS, C\u00e9sar GB, Barbosa PM, Hioka N, Nakamura CV, Bruschi ML, Caetano W (2019) Optimized protocol for multigram preparation of emodin anthrone, a precursor in the hypericin synthesis. Nat Prod Res 33:1196\u20131199. https:\/\/doi.org\/10.1080\/14786419.2018.1457661","journal-title":"Nat Prod Res"},{"key":"3379_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","volume":"345","author":"M Ikeda-Imafuku","year":"2022","unstructured":"Ikeda-Imafuku M, Wang LL-W, Rodrigues D, Shaha S, Zhao Z, Mitragotri S (2022) Strategies to improve the EPR effect: a mechanistic perspective and clinical translation. J Contr Rel 345:512\u2013536. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.043","journal-title":"J Contr Rel"},{"issue":"1","key":"3379_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cll.2017.10.012","volume":"38","author":"AM Ilbawi","year":"2018","unstructured":"Ilbawi AM, Velazquez-Berumen A (2018) World Health Organization list of priority medical devices for cancer management to promote universal coverage. Clin Labor Med 38(1):151\u2013160. https:\/\/doi.org\/10.1016\/j.cll.2017.10.012","journal-title":"Clin Labor Med"},{"key":"3379_CR16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.7150\/thno.6650","volume":"3","author":"B Jiang","year":"2013","unstructured":"Jiang B, Wang J, Ni Y, Chen F (2013) Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging. Theranostics 3:667\u2013676. https:\/\/doi.org\/10.7150\/thno.6650","journal-title":"Theranostics"},{"key":"3379_CR17","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","volume":"98","author":"D Kalyane","year":"2019","unstructured":"Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK (2019) Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C 98:1252\u20131276. https:\/\/doi.org\/10.1016\/j.msec.2019.01.066","journal-title":"Mater Sci Eng C"},{"issue":"2","key":"3379_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1758834012466280","volume":"5","author":"M Khattak","year":"2013","unstructured":"Khattak M, Fisher R, Turajlic S, Larkin J (2013) Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm. Ther Adv Med Oncol 5(2):105\u2013118. https:\/\/doi.org\/10.1177\/1758834012466280","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"3379_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.18553\/jmcp.2014.20.4.346","volume":"20","author":"AJ Olszanski","year":"2014","unstructured":"Olszanski AJ (2014) Current and future roles of targeted therapy and immunotherapy in advanced melanoma. J Manag Care Pharm 20(4):346\u2013356. https:\/\/doi.org\/10.18553\/jmcp.2014.20.4.346","journal-title":"J Manag Care Pharm"},{"key":"3379_CR20","doi-asserted-by":"publisher","unstructured":"Peters MC, Minton A, Phanstiel IV O, Gilmour SK (2018) A novel polyamine-targeted therapy for BRAF mutant melanoma tumors. Medical Sciences. 6(1)3. https:\/\/doi.org\/10.3390\/medsci6010003","DOI":"10.3390\/medsci6010003"},{"issue":"6","key":"3379_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","volume":"17","author":"M Scaranti","year":"2020","unstructured":"Scaranti M, Cojocaru E, Banerjee S, Banerji U (2020) Exploiting the folate receptor \u03b1 in oncology. Nat Rev Clin Oncol 17(6):349\u2013359. https:\/\/doi.org\/10.1038\/s41571-020-0339-5","journal-title":"Nat Rev Clin Oncol"},{"key":"3379_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41557-021-00661-x","volume":"13","author":"AFL Schneider","year":"2021","unstructured":"Schneider AFL, Kithil M, Cardoso MC, Lehmann M, Hackenberger CPR (2021) Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives. Nat Chem 13:530\u2013539. https:\/\/doi.org\/10.1038\/s41557-021-00661-x","journal-title":"Nat Chem"},{"key":"3379_CR23","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1021\/cr010371d","volume":"103","author":"C Schweitzer","year":"2003","unstructured":"Schweitzer C, Schmidt R (2003) Physical mechanisms of generation and deactivation of singlet oxygen. Chem Rev 103:1685\u20131758. https:\/\/doi.org\/10.1021\/cr010371d","journal-title":"Chem Rev"},{"issue":"5","key":"3379_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/antiox10050685","volume":"10","author":"Z Sezgin-Bayindir","year":"2021","unstructured":"Sezgin-Bayindir Z, Losada-Barreiro S, Bravo-D\u00edaz C, Sova M, Kristl J, Saso L (2021) Nanotechnology-based drug delivery to improve the therapeutic benefits of NRF2 modulators in cancer therapy. Antioxidants 10(5):685. https:\/\/doi.org\/10.3390\/antiox10050685","journal-title":"Antioxidants"},{"issue":"1","key":"3379_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.suc.2019.09.013","volume":"100","author":"J Sun","year":"2019","unstructured":"Sun J, Carr MJ, Khushalani NI (2019) Principles of targeted therapy for melanoma. Surg Clin North Am 100(1):175\u2013188. https:\/\/doi.org\/10.1016\/j.suc.2019.09.013","journal-title":"Surg Clin North Am"},{"key":"3379_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"3379_CR27","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-04-2890","volume":"65","author":"T Tran","year":"2005","unstructured":"Tran T, Shatnawi A, Zheng X, Kelley KMM, Ratnam M (2005) Enhancement of folate receptor \u03b1 expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. Cancer Res 65(10):4431\u20134441. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2890","journal-title":"Cancer Res"},{"key":"3379_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","volume":"6","author":"J Wang","year":"2021","unstructured":"Wang J, Li Y, Nie G (2021) Multifunctional biomolecule nanostructures for cancer therapy. Nat Rev Mater 6:766\u2013783. https:\/\/doi.org\/10.1038\/s41578-021-00315-x","journal-title":"Nat Rev Mater"},{"key":"3379_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A (2020) Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci 7:191","journal-title":"Front Mol Biosci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03379-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:58:59Z","timestamp":1738382339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03379-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3379"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03379-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4107279\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experiment was conducted with the approval of the Ethics Committee for Animal Experimentation of the State University of Maring\u00e1, with protocol no. 8843231019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have read and agreed to the published version of the manuscript","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}